Evidence map›Paper›PMID 25803616›Full record

ArticlePloS one2015

A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.

Nancy M Cladel, Lynn R Budgeon, Karla K Balogh, Timothy K Cooper, Jiafen Hu, Neil D Christensen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nancy M CladelThe Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, PA, United States of America; Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Lynn R BudgeonThe Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, PA, United States of America; Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Karla K BaloghThe Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, PA, United States of America; Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Timothy K CooperDepartment of Comparative Medicine, Pennsylvania State University College of Medicine Hershey, PA, United States of America.
Jiafen HuThe Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, PA, United States of America; Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Neil D ChristensenThe Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, PA, United States of America; Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America; Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA, United States of America.
Pennsylvania State University · US

Funding

Papillomavirus Host InterationR01CA047622 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHRISTENSEN, NEIL D · 1988 to 2015
$3.8M
Role of estrous cycle and contraceptives in anogenital papillomavirus infectionR21AI121822 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHRISTENSEN, NEIL D, HU, JIAFEN · 2016 to 2017
$425k
NCI NIH HHS R01 CA047622NIAID NIH HHS R21 AI121822
6 · The paper itself

Abstract

backgroundPapillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged. In addition, the vaccines have not gained wide acceptance in the United States nor do they provide therapeutic value. Papillomaviruses are strictly species specific and thus human viruses cannot be studied in an animal host. An appropriate model for mucosal disease has long been sought. We chose to investigate whether the newly discovered mouse papillomavirus, MmuPV1, could infect mucosal tissues in Foxn1nu/Foxn1nu mice.

methodsThe vaginal and anal canals of Foxn1nu/Foxn1nu mice were gently abraded using Nonoxynol-9 and "Doctor's BrushPicks" and MmuPV1 was delivered into the vaginal tract or the anal canal.

resultsProductive vaginal, cervical and anal infections developed in all mice. Vaginal/cervical infections could be monitored by vaginal lavage. Dysplasias were evident in all animals.

conclusionsAnogenital tissues of a common laboratory mouse can be infected with a papillomavirus unique to that animal. This observation will pave the way for fundamental virological and immunological studies that have been challenging to carry out heretofore due to lack of a suitable model system.

Indexed as

Anal CanalAnimalsCervix UteriDisease Models, AnimalFemaleForkhead Transcription FactorsHumansMicePapillomaviridaePapillomavirus InfectionsUnited StatesVaginaVaginal SmearsForkhead Transcription FactorsWhn protein

Identifiers

PMID25803616
PMCPMC4372414
OpenAlexW2060707992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.